|
|
|
Journal of the American Medical Association.gov/vaccines/pubs/pinkbook/default. Additionally, mice receiving AEOL 10150 experienced a reversal in weight loss seen in the untreated mice. of Duke University. McManus, President and Chief Executive Officer of Aeolus Pharmaceuticals, Inc.
-- Advanced Development Stage – AEOL 10150 has demonstrated safety in three human clinical trials, and has an extensive pre-clinical safety and toxicology package completed.
Potential for AEOL 10150 as a Countermeasure Against Multiple Terrorist Threats
AEOL 10150 has shown significant protective effects against radiation and mustard gas in animal models. AEOL 10150 is a patented, small molecule catalytic antioxidant that mimics and thereby amplifies the body's natural enzymatic systems for eliminating reactive oxygen species, or free radicals.
xanax klonopin buying prescription valium without xanax drug testing xanax weaning protocol xanax xanax bars photos xanax no prescription 180
The dynamic and unpredictable nature of meningococcal disease epidemiology warrants a vaccine that offers broad serogroup protection[6]. You should not place undue reliance on these statements.
Data to Be Presented at the 55th Annual Meeting of the Radiation Research Society in October
MISSION VIEJO, Calif. In previous studies it has been shown that doses in the range of 5 to 30 mg/kg AEOL 10150 given daily starting up to 24 hrs after irradiation and administered for as long as 10 weeks mitigate functional lung injury in Fischer 344 rats.”
About AEOL 10150
AEOL 10150 is a small molecule that catalytically consumes reactive oxygen and nitrogen species (free radicals).
|
|
No News has been posted yet
|
|
|
Forgotten your password? Request a new one here.
|
 Guests Online: 1
No Members Online
Registered Members: 1
Unactivated Members: 0
Newest Member: Owen Electrical
|
|
v6.01.1 © 2003-2005